News
The tennis superstar has spoken about her health issues to raise awareness — and now taken on a role to help women prioritize ...
A California addiction center found a way to compel Anthem to cover patients it rejected. Their dispute reflects a broader ...
Real Housewives of Beverly Hills' star Kathy Hilton gives guests a chance to sample 'the latest, the greatest machines for ...
22h
Glamour on MSNWNBA All-Star Game 2025: Caitlin Clark Opens Up About Injury Recovery, Her Mental-Health Musts, and the One Health Stat Every Woman Should Know
As a pro athlete, Caitlin Clark has access to some of the most innovative wellness treatments—red-light therapy, dry needling ...
5d
Zacks Investment Research on MSNHims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Hims & Hers Health, Inc. (HIMS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want ...
Nancy Sinatra, 85, Sends Urgent Warning About 'Fake News' Involving Her Health originally appeared on Parade. Nancy Sinatra ...
Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to ...
Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...
1d
Zacks Investment Research on MSNHere's Why Hims & Hers Health, Inc. (HIMS) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $870,000,000 aggregate principal amount of 0.00% convertible senior ...
Hims & Hers Health guided for second-quarter revenue of $530 million to $550 million versus estimates of $564.56 million. The company said it continues to expect full-year 2025 revenue in the ...
Hims & Hers Health also provided a longer-term outlook, laying out expectations for at least $6.5 billion in annual revenue for full-year 2030, and adjusted EBITDA of at least $1.3 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results